OrthoPediatrics Corp.KIDSNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
8.06%
↑ 25% above average
Average (39q)
6.45%
Historical baseline
Range
High:90.34%
Low:-36.20%
Volatility
1960.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 8.06% |
| Q2 2025 | -8.17% |
| Q1 2025 | -19.38% |
| Q4 2024 | 13.15% |
| Q3 2024 | 1.34% |
| Q2 2024 | -15.18% |
| Q1 2024 | 9.14% |
| Q4 2023 | 7.26% |
| Q3 2023 | -13.65% |
| Q2 2023 | 30.66% |
| Q1 2023 | 11.60% |
| Q4 2022 | -7.80% |
| Q3 2022 | 26.27% |
| Q2 2022 | -13.81% |
| Q1 2022 | 26.06% |
| Q4 2021 | 23.50% |
| Q3 2021 | -1.74% |
| Q2 2021 | 1.30% |
| Q1 2021 | -36.20% |
| Q4 2020 | 90.34% |
| Q3 2020 | 22.25% |
| Q2 2020 | -30.36% |
| Q1 2020 | -33.60% |
| Q4 2019 | 36.46% |
| Q3 2019 | 13.13% |
| Q2 2019 | 1.73% |
| Q1 2019 | -5.01% |
| Q4 2018 | 13.81% |
| Q3 2018 | 0.63% |
| Q2 2018 | -8.46% |
| Q1 2018 | 29.44% |
| Q4 2017 | -16.50% |
| Q3 2017 | 68.71% |
| Q2 2017 | -2.77% |
| Q1 2017 | 10.10% |
| Q4 2016 | 24.55% |
| Q3 2016 | -14.94% |
| Q2 2016 | 16.17% |
| Q1 2016 | 0.00% |
| Q1 2015 | 0.00% |